Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Completed 47Terminated 24Active not recruiting 16Recruiting 11Withdrawn 4Unknown 4Not yet recruiting 4Suspended 2

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4Other hematologic neoplasm 1

Conditions

Lymphoma, Large B-Cell, Diffuse 55Lymphoma, Non-Hodgkin 20Lymphoma 17Lymphoma, Mantle-Cell 13Lymphoma, Follicular 12Recurrence 10Leukemia, Lymphocytic, Chronic, B-Cell 10Burkitt Lymphoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, B-Cell, Marginal Zone 4Lymphoma, B-Cell 4Hodgkin Disease 4Myelodysplastic Syndromes 3Waldenstrom Macroglobulinemia 2Neoplasms 2Lymphoma, Large-Cell, Immunoblastic 2Leukemia 2Dendritic Cell Sarcoma, Interdigitating 2Pyloric Stenosis, Hypertrophic 1Plasmablastic Lymphoma 1Neuroblastoma 1Neoplasms by Histologic Type 1Myasthenia Gravis 1Melanoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1

Interventions

Cyclophosphamide 16fludarabine 12Rituximab 4Immunotherapy, Adoptive 4Antigens, CD19 4Lenalidomide 3Etoposide 3orelabrutinib 2Nivolumab 2N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2Methotrexate 2Cell- and Tissue-Based Therapy 2zanubrutinib 1selinexor 1relmacabtagene autoleucel 1prednylidene 1obinutuzumab 1merphos 1ixazomib 1gemcitabine-oxaliplatin regimen 1fludarabine phosphate 1entecavir 1eltrombopag 1deltacortene 1abivertinib 1Vincristine 1Transplantation, Autologous 1Tenofovir 1Prednisone 1Pentostatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Lymphoma, B-Cell × Rituximab × Clear all
NCT05379647 2022-05-18

Natural Killer (NK) Cell Therapy for B-Cell Malignancies

Zhejiang University

Phase 1 Unknown
24 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, B-Cell

NCT02481310 2022-02-21

Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma

Northwestern University

Phase 1/2 Unknown
38 enrolled 12 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT02456207 2015-05-28

A Pharmacokinetic Study Comparing SCT400 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma

Sinocelltech Ltd.

Phase 2 Unknown
80 enrolled
Lymphoid

Lymphoma, B-Cell

NCT00927797 2009-06-25

PERLL

Heidelberg University

Phase 2 Unknown
185 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡